Physician

Maurice L King, M.D.

According to 2025 Medicare claims, Maurice King, M.D. (NPI: 1194817411) practices radiation oncology in the Houma-Bayou Cane-Thibodaux, LA market, with the plurality of this provider's patient population coming from Lafourche, LA. This provider's primary affiliated billing organization is ST. ELIZABETH-MARY BIRD PERKINS CANCER CENTER, L.L.C. (NPI: 1619155124; TIN: 260628752) and primary practice location at 70737-5003.

King's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 525 traditional Medicare patients, billed 16,171 HCPCS/CPT codes, and received $905,553 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 179 prescription claims across 88 beneficiaries totaling $2,695 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 3 records totaling $55. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $13,559 to $2,695. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	393	10,444	$516,527
2016	431	9,110	$521,477
2017	343	7,209	$389,062
2018	352	7,509	$456,770
2019	334	9,818	$482,860
2020	361	6,479	$423,753
2021	309	5,296	$368,538
2022	397	9,104	$654,245
2023	482	19,715	$633,740
2024	525	16,171	$905,553

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	107	313	$13,559
2016	89	252	$11,346
2017	79	203	$8,678
2018	78	200	$6,232
2019	92	226	$5,099
2020	87	193	$3,246
2021	83	219	$3,333
2022	88	174	$2,832
2023	94	195	$2,966
2024	88	179	$2,695

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78815	Nuclear medicine study from skull base to mid-thigh with ct scan	62	71	$1,028
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	154	644	$239
77014	Ct guidance for insertion of radiation therapy fields	184	735	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	74	104	$62
77336	Continuing radiation therapy consultation per week	75	143	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	53	3,450	$520
Dexamethasone	Dexamethasone	12	272	$275
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	96	$210
Triamcinolone Acetonide	Triamcinolone Acetonide	15	259	$121
Lorazepam	Lorazepam	20	43	$23

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$55	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Maurice L. King, M.D.?

Tedicare shows public-source Medicare data for Maurice L. King, M.D. (NPI 1194817411), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maurice L. King, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Maurice L. King, M.D.?

Maurice L. King, M.D. is linked to ST. ELIZABETH-MARY BIRD PERKINS CANCER CENTER, L.L.C. (billing NPI 1619155124) in the available physician profile data.

Does Maurice L. King, M.D. have Open Payments data?

Maurice L. King, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.